PEOPLE - DCA Design Consultants (UK) makes appointment:
This article was originally published in Clinica
Robert Woolston has been appointed director of medical and scientific product design at DCA Design Consultants in the UK. Mr Woolston, formerly managing senior designer at Sams Design, also in the UK, specialises in design for high volume plastics device manufacture, which includes drug delivery devices such as injectors and inhalers, as well as diagnostic products and technical packaging.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.